Related Experiment Video
Updated: May 26, 2026
06:49
Monitoring Protein Aggregation Kinetics In Vivo using Automated Inclusion Counting in Caenorhabditis elegans
Published on: December 17, 2021
Protein aggregation in congenital myopathies
Hans H Goebel1, Astrid Blaschek
1Department of Neuropathology, University Medical Center of Johannes Gutenberg University, Mainz, Germany. goebel@neuropatho.klinik.uni-mainz.de
Seminars in Pediatric Neurology
|December 17, 2011
Summary
Protein aggregation in congenital myopathies indicates issues with protein breakdown (catabolism) or muscle development (anabolism). This affects myofibrillar myopathies like desminopathy and actin filament aggregating myopathy (AFAM).
Area of Science:
- Muscle physiology and pathology
- Molecular biology of proteinopathies
Background:
- Congenital myopathies are characterized by protein aggregation within muscle fibers.
- Specific types include granulofilamentous myopathy, cytoplasmic body myopathy, spheroid body myopathy, cap disease, and reducing body myopathy.
- These aggregations are linked to specific mutant proteins like alphaB crystallin, desmin, and myotilin.
Purpose of the Study:
- To investigate the underlying mechanisms of protein aggregation in various congenital myopathies.
- To differentiate between catabolic and anabolic disturbances contributing to muscle pathology.
Main Methods:
- Analysis of protein aggregates in muscle biopsies from patients with different congenital myopathies.
- Identification of aggregated proteins and assessment of their relationship to disease type.
Main Results:
- Diverse proteins aggregate in conditions like cap disease and reducing body myopathy, suggesting impaired protein degradation (catabolism).
- Actin filament aggregating myopathy (AFAM) and hyaline body myopathy (HBM) show accumulation of mutant sarcomeric proteins, indicating defects in sarcomere maturation and integration (anabolism).
Conclusions:
- Protein aggregation in congenital myopathies stems from either impaired protein catabolism or defective sarcomere assembly (anabolism).
- Understanding these distinct pathways is crucial for diagnosing and potentially treating these muscle disorders.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...